Awareness Days

National Women and Girls HIV/AIDS Awareness Day

According to CDC, 7,312 women were newly diagnosed with HIV in 2017. That number represents 19% of all new HIV diagnoses in the United States.

Vu Q&A

Vu Q&A: Dr. Oni Blackstock on HIV Among Women and Vulnerable Populations

Oni Blackstock, MD, MHS, Assistant Commissioner, NYC Department of Health and Clinical Assistant Professor at Albert Einstein College of Medicine, spoke about how to reduce new HIV diagnoses among women, especially sex workers, injection drug users, and trans women.

Vu Q&A

Vu Q&A: Raniyah Copeland on the Future of HIV in the Black Community

Raniyah Copeland, MPH, President and CEO of Black AIDS Institute, talks about the history of National Black HIV/AIDS Awareness Day as well as her vision for the future of Black AIDS Institute.

A Year in Review: AIDSVu’s 2018 Highlights

As 2018 draws to a close, AIDSVu looks back on some of the year's highlights. From our most-shared infographics, to cutting edge insights from our AC members, to some fascinating Q&As with HIV thought leaders, AIDSVu has had an eventful year.

Awareness Days

World AIDS Day 2018

Today on the 30th anniversary of World AIDS Day, AIDSVu looks back on three decades of HIV milestones and the progress many jurisdictions are making towards Ending the Epidemic.

Vu Q&A

Vu Q&A: The Washington State Department of Health on the End AIDS Washington Campaign

AIDSVu recently spoke with Claudia Catastini and Tamara Jones of the Washington State Department of Health about the End AIDS Washington Campaign. Initiated in 2014, the Washington State campaign was one of the first in the U.S.

Vu Q&A

Vu Q&A: NASTAD on Ending the Epidemic plans across the U.S.

Ann Lefert and Natalie Cramer of NASTAD talk about Ending the Epidemic throughout the country and NASTAD's recently released interactive map of plans across the U.S.

A Year in Review: AIDSVu’s 2018 Highlights

As 2018 draws to a close, AIDSVu looks back on some of the year's highlights. From our most-shared infographics, to cutting edge insights from our AC members, to some fascinating Q&As with HIV thought leaders, AIDSVu has had an eventful year.

AIDSVu Adds 2017 State-Level Data Visualizing PrEP Users Across the U.S.

PrEP utilization data reveal that the number of PrEP users increased by 29% from 2016 to 2017, continuing a trend of consistent growth in PrEP use since 2012. However, significant disparities exist across different sexes, age groups, and geographic regions.

Vu Q&A: Dr. Bisola Ojikutu on the Barriers to PrEP Use Among African Americans

Dr. Bisola Ojikutu, MD, MPH, adjunct faculty member at The Fenway Institute and Assistant Professor of Medicine at Harvard Medical School and Infectious Disease Physician at Massachusetts General Hospital speaks about the barriers to PrEP use among African Americans.

Vu Q&A: Yusuf Ransome on PrEP Use Through the Lens of Social and Behavioral Sciences

Yusuf Ransome, MPH, DrPH, Assistant Professor of Social and Behavioral Sciences at the Yale University School of Public Health talks about PrEP use through the lens of social and behavioral sciences.